Applications for the Rhodes Scholarship 2026 are open! Click here to learn more.

Applications for the Rhodes Scholarship 2026 are open! Click here to learn more.

Open

Jane Larkindale

New Zealand & New College 1988

Born in Vienna in 1975, Jane Larkindale studied at the University of Otago in New Zealand before going to Oxford to read for a DPhil in plant sciences. After moving to the US to take up postdoctoral study, she settled in Arizona, working first at the University of Arizona, then at several nonprofit organizations that focussed on acceleration of therapy development for neuromuscular diseases, finally moving to a small biotech company developing therapies in this area. Larkindale has been Vice President of Research Development at Friedreich’s Ataxia Research Alliance and the Muscular Dystrophy Association and Executive Director of several consortia at the Critical Path Institute. She is currently Vice President of Clinical Sciences at PepGen. This narrative is excerpted from an interview with the Rhodes Trust on 18 April 2025.  

‘The constants in my life were reading and the outdoors’ 

My father was a diplomat which meant our family moved around a lot. After Austria, where I was born, we went to Washington, DC and then back to New Zealand (my native country), where I started to school. Then we moved to Western Samoa. My father was working for the islands of Tokelau which were a three-day boat trip from where we lived, so he was gone quite a bit during that time. We were there for a few years and then we moved to Beijing, then to New Zealand again and then to London.  

I went to some phenomenally good schools and some phenomenally bad ones, and I learned a lot from both types. I would say my years in my high school in New Zealand were probably the best. In all, I did a lot of self-education which I think in the greater scheme of things is really good. The constants in my life were reading and the outdoors. I never really watched TV or had access to movies, but books were huge, and wherever we were, we always found ways to explore and have adventures outside. 

I certainly was aware from a young age that I was a relatively rich white person. We always had access to education and books, always had food and clothes. When we were living in China, it was pre-Tiananmen, so we knew we had liberties other people didn’t. Just understanding the world and seeing all those different experiences and drivers was really important to me.  

On applying for the Rhodes Scholarship 

I always wanted adventure, to travel and to be outdoors, and I think what attracted me to science early on was that I wanted to be Jane Goodall, studying animals. I was also very much into environmentalism. Alongside that, I was also very attracted to physics and mathematics. That split was reflected in my first degree, where I ended up with a double major in physics and plant biotechnology. For my honours thesis, I had the option of doing a very biochemical project or of doing one that was more to do with physiology, and I chose the physiology because it meant I could go to the beach at least once a week to do fieldwork.  

I knew I wanted to do a PhD, and my father had been a Commonwealth Scholar, so I just applied for a bunch of scholarships. For the Rhodes, we went to Wellington for the final interviews and when they announced I’d got it, I was very surprised, because when you’re surrounded by a bunch of really, really brilliant people you never think you’re one of them.  

‘It was an incredibly lucky choice’ 

Aside from the fact that it was a beautiful town, I’d never really thought seriously about going to Oxford. At university in New Zealand, I had fallen into some botany classes and become very interested in the question of how we could grow crops and feed people in a climate change world. At Oxford, there was a group working on environmental stresses and plants. I already knew their research and it was an incredibly lucky choice. We were known as the “smug lab” because we were the best supervised and we had the most fun. I think for scientists at Oxford, your lab and your research group is at least important as your college, and I had friends both in college and in the department.   

I did go to Rhodes House, especially for some of the talks there, and it was a good place for just meeting people and discussing things outside of our academic disciplines. I was part of the Oxford Univesrity walking club too, and we did a lot of weekend trips to the Peak District or the Lake District or Cornwall. I was also on the fencing team and we had tournaments across the UK. We had a good time.  

‘My job was about helping people see that we all had the same endpoint’ 

After my PhD, I went to the US, but I realised I’d made a very poorly researched move. The lab I went to at Rutgers to do molecular biology was not set up for doing that kind of research. I spent around eight months there, and it was an interesting time, just after 9/11, when there was a big backlash against foreign students, to the extent that we couldn’t get driving licences. I could cycle for a few hours down the canal path to visit my cousin who was at Princeton, or get the train to go to Manhattan, and that was about it. Then, the woman who was the world expert on heat stress and plants was advertising for a postdoc in Arizona. I knew I wanted to work with her, but I had this idea that I couldn’t live in Arizona, because I wouldn’t live in a desert. I applied anyway, and when I went out to interview and spend a weekend in Tucson, I thought, ‘This is not at what my prejudices said it would be. It’s not flat, it’s not sandy. It’s kind of fascinating.’  

I spent about five years doing postdoc work in the University of Arizona. Arizona has a way of getting its hooks into you, and it was also there that I met my husband. We had both independently decided to volunteer to search and rescue in the Arizona mountains. I began to realise I was getting more of that volunteer work than I was getting from my research. I liked being in a position to give back, to help people. I remember the moment I started really thinking about it was when I was talking to another search and rescue team member. He said, ‘What do you want to do?’ I said, ‘Change the world,’ and he said, ‘That’s what we’re doing right now. We’re changing the world, one person at a time.’  

I was in a bit of a rut with my research too, and then I saw an ad saying that the Muscular Dystrophy Association (MDA) was looking for a research coordinator. It was really just processing grants, but my boss there was looking to get some new ideas going, including investing in early stage companies that would develop drugs for rare diseases. We had some initial seed funding and we got this whole venture philanthropy programme going. Over the course of a few years, we funded about 20 companies, and some of the drugs they developed are now on the market. When my boss left, I took over her job and began to oversee and run the research programmes, and continued to work with the companies and really see how drug development worked.  

I left MDA because there was a global recession and they’d basically cut all the funding for the research programmes. I hadn’t lined up another job, which was a bit scary, but I decided to form a consulting company, reaching out to the companies and nonprofits I’d worked with and basically saying, ‘What can I help you with?’ I wrote a lot of regulatory documents, grant applications and strategic plans. It was around that time my daughter was a baby and in preschool, and the work gave me a lot of flexibility. Over time, much of my time got taken over by two clients – the Friedreich’s Ataxia Research Alliance (FARA) and the Critical Path Institute (C-Path).  At FARA I ran multiple projects seeking to find treatments and cures for Friedreich’s Ataxia.  I still work with this group as much as I can – there’s still work to be done there! At the same time, C-Path asked me to lead a consortium to help define regulatory pathways to accelerate drug development for drugs for Duchenne muscular dystrophy. The emphasis was on sharing data on biomarkers and disease progression models. This eventually expanded into other rare diseases, and eventually to launching a database for sharing data across all rare conditions.  My job was about helping people see that we all had the same endpoint, that we were all going to benefit.  

‘Where will the Rhodes Scholarship go next?’ 

I joined the team at PepGen in 2021. We have a platform technology that delivers oligonucleotides to the body in a way that helps the muscles for sufferers of both Duchenne muscular dystrophy and myotonic dystrophy. It’s wonderful work and I love doing it, but when somebody asked me the other day, ‘What’s your biggest vice?’ I had to say, ‘Running away into the mountains where there’s no cell phone contact and none of you can reach me.’ My husband and daughter and I spent a lot of time outdoors as a family. Where I live now, I can go and run in the mountains and I’m not giving that up for anything! 

The Rhodes Scholarship had a huge impact on my life. I think of the history of the Scholarship, going from a man who said he wanted to make the world English, to where we are now. Where will the Rhodes Scholarship go next? I’d like to see it offer opportunities to more diverse people. I always think of the friend I went to Oxford with who was 100% smarter than me but who had not had the chance to travel the world and have the formative experiences I was privileged to have. Those are the people who can really change the world.  

Transcript

Share this article